KILN

Home / ISO 11608 testing

ISO 11608 testing for pen injectors and autoinjectors

Design verification for pens, autoinjectors and other needle-based injection systems, run on your device with your primary container, using methods built and validated for that system.

What ISO 11608 covers

ISO 11608 is the series of standards for needle-based injection systems: devices that deliver a drug through a needle from a cartridge or a prefilled syringe.

Part 1 sets the general requirements and test methods for these systems, including dose accuracy. Part 3 covers the container and integrated fluid path, and Part 5 covers automated functions such as automatic needle insertion and injection. Which parts apply depends on how your device works, and that question is settled during scoping, before any protocol is written. We run all of the test annexes in the parts that apply.

Most autoinjector problems start at the interface between the device and the syringe inside it. A spring sized for one syringe and stopper can run slow with another, and a formulation that thickens in the cold can push injection time past its limit. Verification has to be run on the real combination, so that is how we run it.

  1. Remove capCap removal force, needle shield removal
  2. Press to activateActivation and override force
  3. InjectInjection time and depth, delivered dose, click-to-click time
  4. WithdrawNeedle shielding and lockout
The use sequence of a typical autoinjector, and the verification tests that apply at each step.

What we test

Tests are chosen from your design inputs and the applicable parts of the standard. These are the ones we run most often.

Device function

How the device behaves when a user picks it up and injects.

Dose accuracy and delivered volume

Delivered dose and deliverable volume for single-dose autoinjectors, and dose accuracy across the dose settings of multi-dose pens. Formulation density is measured so that results can be reported as volume.

  • Dose accuracy
  • Deliverable volume
  • Density

Activation and injection

Cap removal, activation and override force, injection time, injection depth and click-to-click time, measured on fixtures built for your device.

  • Activation force
  • Injection time
  • Injection depth

Needle shielding

Needle shielding and separation force for devices with integrated safety features, so that the safety function is verified alongside the injection.

  • Shielding
  • Separation force

Power pack simulation

The force profile of the device's drive spring is measured and then reproduced against candidate syringes and stoppers filled with a viscosity-matched solution. The result is a predicted injection time for each combination, before full devices are available.

  • Spring force profile
  • Injection time
  • Viscosity

Container and conditions

The primary container inside the device, and the device after storage and shipping.

Container and fluid path

Cartridge and plunger leakage, needle leakage, and septum fragmentation and resealability under repeated needle penetration, for pens and cartridge-based devices.

  • ISO 11608-3
  • Fragmentation
  • Resealability

Aging, preconditioning and transit

Functional tests repeated after real-time and accelerated aging, environmental preconditioning and distribution simulation, so that verification covers the device as the patient receives it.

  • Aging
  • Preconditioning
  • Transit simulation

The syringe inside the device

Break-loose and glide force, critical dimensions and silicone distribution of the primary container, so that device results can be traced back to the container. See ISO 11040 testing.

  • Break-loose and glide
  • Dimensions

Reference product benchmarking

For generic and biosimilar programs, the reference product's pen and cartridge are characterized side by side with yours: dimensions, dose accuracy, forces and leakage.

  • Reference listed drug
  • Multi-dose pens

How we work

Work is structured in phases with clear deliverables at each gate, so you always know what you have paid for and what comes next.

  1. Scope

    We review the device, the container, your design inputs and regulatory plan, and agree which requirements apply. You get a phased proposal with sample quantities.

  2. Develop

    Fixtures are built for your device and each method is optimized, using placebo or a viscosity-matched surrogate where possible to save drug product.

  3. Validate

    Three test series by two operators on different days establish method precision. You receive the validation protocol, report and final test method.

  4. Test

    Verification runs against the validated methods at time zero and after aging, preconditioning and transit, as your plan requires.

  5. Support

    Methods stay available for stability pulls, investigations and lot release, or transfer to your own lab with fixtures and training.

Deliverables

Deliverables are defined in the proposal before work starts. A typical engagement includes the following.

Test plan and protocolsWritten for your device and design inputs before testing starts
Validated test methodsValidation protocol, report and final method for each test
Verification reportResults against acceptance criteria, with raw data in spreadsheet form
Fixtures and transferA matched set of fixtures and analyst training, if you want to run the method in-house

Related services

ISO 11040 testingComponent and finished-syringe testing for prefilled syringes and cartridges
Container closure integrity testingLeak test methods developed and validated under USP <1207> and ASTM F2391
Device assembly and packagingDevelopment builds with force and torque monitored on every unit
Human factorsMaterials and surrogates for human factors studies, with partners on retainer who run the studies
Devices we supportPrefilled syringes, cartridges, autoinjectors, pens, wearables and more

Questions we hear often

If yours isn't here, it's a good thing to bring to a consultation.

Which parts of ISO 11608 apply to my device?

It depends on the device. Part 1 applies to needle-based injection systems in general. Part 3 covers the container and integrated fluid path, and Part 5 covers automated functions such as automatic needle insertion or injection. We review your device and design inputs during scoping and agree the applicable requirements with you before any protocol is written.

Can you predict injection time before we have devices?

Yes. We measure the force profile of the drive spring and reproduce it against your candidate syringes and stoppers, filled with a solution matched to your formulation's viscosity. That gives a predicted injection time for each combination while the device is still in development.

Can you test with placebo instead of drug product?

In most cases, yes. Method development is typically done with placebo or a surrogate solution matched to your formulation's key properties, such as viscosity and density. Drug product is reserved for the testing where it matters.

Do you test devices from any supplier?

Yes. We are platform-independent. Fixtures and methods are built around your specific device and primary container, whether it is a platform device or a custom design.

Can the methods be transferred to our lab?

Yes. We can develop and validate a method, build a matched set of fixtures for your equipment, and train your analysts on site.

Planning ISO 11608 testing?

Tell us about the device, the container and where you are in development. We'll set up a call to talk through scope, samples and timing.

Prefer email? Write to info@kiln-lab.com or call +1 (866) 350-8240.